• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Researchers Derive Algorithm to Predict Sepsis-Associated Mortality

August 2, 2013

Bacterial contamination is the most common infectious risk of blood products. It now may be possible to predict patient survival following community-acquired sepsis by using clinical features and metabolomics, according to new research published in the journal Science Translational Medicine. Researchers found that the plasma metabolomes and proteomes of patients who ultimately died from sepsis differed significantly from those who would survive. Specifically, they found differences in proteins and metabolites involved in fatty acid transport and β-oxidation, gluconeogenesis, and the citric acid cycle. These differences were found to increase over time as death approached. An algorithm based upon five of these metabolites and clinical features may help to guide patient-specific treatment of sepsis.

Reference

1.    Langley RJ, Tsalik EL, Velkinburgh JC, Glickman SW, Rice BJ, Wang C, Chen B, Carin L, Suarez A, Mohney RP, Freeman DH, Wang M, You J, Wulff J, Thompson JW, Moseley MA, Reisinger S, Edmonds BT, Grinnell B, Nelson DR, Dinwiddie DL, Miller NA, Saunders CJ, Soden SS, Rogers AJ, Gazourian L, Fredenburgh LE, Massaro AF, Baron RM, Choi AM, Corey GR, Ginsburg GS, Cairns CB, Otero RM, Fowler VG, Jr., Rivers EP, Woods CW, Kingsmore SF. An integrated clinico-metabolomic model improves prediction of death in sepsis. Sci Transl Med 2013;5: 195ra95.

Filed Under

  • News
  • Transfusion Transmitted Infections

Recommended

  • Gene Therapy for β-Thalassemia Patients who Are Transfusion Dependent

  • Traditional Chinese Herbs Not Effective for Intracerebral Hemorrhage: A Randomized Trial

  • Universal Donor Red Blood Cells Can Be Genetically Engineered Using CRISPR Gene Editing

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Array-based, comprehensive genotyping for erythroid, platelet, neutrophil and leukocyte antigens

  • Acute Normovolemic Hemodilution Does Not Reduce RBC Transfusions

  • Blood Donation Teams—a Novel Strategy to Support Novice Donors

  • Plasma Exchange to Reduce Biological Age

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley